期刊文献+

肠道微生态与非消化道疾病 被引量:12

原文传递
导出
摘要 人体肠道内栖息着400多种菌群,14个菌属,共同构成了人体肠道的微生态环境。随着对肠道微生态结构与功能研究的不断深入,肠道菌群对机体健康的重要性逐步被认识。肠道菌群不仅与一些消化道疾病密切相关,还可能参与了一些消化道外疾病的发病机制。已有文献报道了肠道微生态环境改变与心脑血管疾病、呼吸系统疾病、肾脏疾病、内分泌代谢性疾病、神经精神性疾病等的关系,关于这些领域的研究正在逐步兴起和深入。
出处 《中华消化杂志》 CAS CSCD 北大核心 2013年第12期819-821,共3页 Chinese Journal of Digestion
  • 相关文献

参考文献13

  • 1Karlsson FH, Fak F, Nookaew I, et al. Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat Commun, 2012,3:1245.
  • 2Stock J. Gut microbiota: an environmental risk factor for cardiovascular disease. Atherosclerosis, 2013,229:440-442.
  • 3Tang WH, Wang Z, Levison BS,et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med, 2013,368:1575-1584.
  • 4Inoue K, Shirai T, Ochiai H, et al. Blood pressure lowering effect of a novel fermented milk containing gamma-amino butyric acid (GABA) in mild hypertensives. Eur J Clin Nutr, 2003,57:490-495.
  • 5Verhulst Sir, Vael C, Beunckens C, et al. A longitudinal analysis on the association between antibiotic use, intestinal microflora, and wheezing during the first year of life. J Asthma, 2008,45:828-832.
  • 6Russell SL, Gold MJ, Hartmann M, et al. Early life antibiotic driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Rep, 2012,13:440-447.
  • 7Morimoto K, Takeshita T, Nanno M, et al. Modulation of natural killer cell activity by supplementation of fermented milk containing Lactobacillus casei in habitual smokers. Prey Med, 2005,40:589-594.
  • 8Vaziri ND. CKD impairs barrier function and alters microbial flora of the intestine: a major link to inflammation and uremic toxicity. Curr Opin Nephrol Hypertens, 2012,21: 587-592.
  • 9Zheng X, Zhao A, Xie G, et al. Melamine induced renal toxicity is mediated by the gut microbiota. Sci Transl Med, 2013,5: 172-222.
  • 10Ley RE, Turnbaugh PJ, Klein S, et al. Microbial ecology: human gut microbes associated with obesity. Nature, 2006, 444:1022-1023.

同被引文献137

  • 1Min Kyung Jeon,Christina Klaus,Elke Kaemmerer,Nikolaus Gassler.Intestinal barrier:Molecular pathways and modifiers[J].World Journal of Gastrointestinal Pathophysiology,2013,4(4):94-99. 被引量:10
  • 2Zi-Kai Wang,Yun-Sheng Yang.Upper gastrointestinal microbiota and digestive diseases[J].World Journal of Gastroenterology,2013,19(10):1541-1550. 被引量:8
  • 3丁连安,黎介寿.胃肠道生理功能的再认识与肠衰竭[J].世界华人消化杂志,2005,13(14):1650-1651. 被引量:19
  • 4杨娟,郑青山.Meta分析的统计学方法[J].中国临床药理学与治疗学,2005,10(11):1309-1314. 被引量:58
  • 5沈镭,陆伦根.肠道微生态与肝硬化[J].肝脏,2006,11(4):278-280. 被引量:11
  • 6沈晓明,王卫平.儿科学[J].北京:人民卫生出版社,2008.
  • 7Borody T. J, Khoruts A. Fecal microbiota transplan- tation and emerging applications [ J ]. Nat Rev Gas- troenterol Hepato1,2011,9 (2) :88 - 96.
  • 8Surawicz C. M, Brandt L. J, Binion D. G, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections [ J ]. Am J Gastro- entem1,2013,108 (4) :478 - 498.
  • 9Khoruts A. Fecal microbiota transplantation in 2013 : developing human gut microbiota as a class of thera- peutics [ J ]. Nat Rev Gastroenterol Hepatol,2014,11 (2) :79 -80.
  • 10Gough E, Shaikh H, Manges A. R. Systematic Re- view of Intestinal Microbiota Transplantation ( Fecal Bacteriotherapy) for Recurrent Clostridium difficile Infection[ J]. Clinical Infectious Diseases,2011,53 (10) :994-1002.

引证文献12

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部